de Moura M C, Ramalho F
Dig Dis Sci. 1979 Jul;24(7):514-20. doi: 10.1007/BF01489318.
E rosette-forming cells (E-RFC) and active E-RFC were studied in the peripheral blood in patients with chronic active hepatitis (CAH), chronic persistent hepatitis (CPH), and in control subjects. A significant reduction in active E-RFC (a subpopulation of T lymphocytes considered actively involved in cell-mediated immune reactions) was found in patients with untreated CAH, both HBSAg positive or negative. In contrast, patients with immunosuppressive-treated CAH showed an increased relative number of active E-RFC. A significant increase in active E-RFC was demonstrable in other immunosuppressive-treated chronic inflammatory disorders. In CPH active E-RFC were not different from normal controls. The number of E-RFC showed a relative and absolute decrease in both CPH and untreated CAH. These studies demonstrate an increase in active E-RFC in immunosuppressive-treated CAH and suggest that prednisone and azathioprine may have a differential effect on T lymphocyte subpopulations.
对慢性活动性肝炎(CAH)、慢性持续性肝炎(CPH)患者及对照者的外周血中的E玫瑰花结形成细胞(E-RFC)和活性E-RFC进行了研究。在未经治疗的CAH患者中,无论乙肝表面抗原(HBSAg)阳性或阴性,均发现活性E-RFC(被认为积极参与细胞介导免疫反应的T淋巴细胞亚群)显著减少。相比之下,接受免疫抑制治疗的CAH患者显示活性E-RFC的相对数量增加。在其他接受免疫抑制治疗的慢性炎症性疾病中,活性E-RFC也有显著增加。在CPH中,活性E-RFC与正常对照无差异。E-RFC的数量在CPH和未经治疗的CAH中均出现相对和绝对减少。这些研究表明,接受免疫抑制治疗的CAH中活性E-RFC增加,提示泼尼松和硫唑嘌呤可能对T淋巴细胞亚群有不同作用。